TP53 and breast carcinoma: For example, Vitamin D and its two analogues, EB 1089 and CB 1093, which activate CIPCD in breast cancer cell lines, MCF7 and T 47D, by activating cathepsin D and are inhibited by Bcl-2, but do not require p53 or the caspases [65].